Description
NSE notifies commencement of trading in Rights Entitlements (REs) of Sunrest Lifescience Limited on the SME EMERGE platform effective April 02, 2026, with renunciation window open until April 27, 2026.
Summary
NSE has admitted Rights Entitlements (REs) of Sunrest Lifescience Limited to trading on the Capital Market segment (SME EMERGE) effective April 02, 2026, under symbol SUNREST-RE (Series: ST, ISIN: INE0PLZ20012). The REs will trade in the Trade to Trade segment in compulsory demat mode. The trading window for renunciation runs from April 02, 2026 to April 27, 2026, after which unsubscribed and un-renounced REs will lapse.
Key Points
- Symbol: SUNREST-RE; Series: ST; ISIN: INE0PLZ20012
- Total Rights Entitlements available for trading: 4,291,200
- Market lot size: 1,600 REs
- Trading platform: NSE Capital Market segment — SME EMERGE
- REs will trade in the Trade to Trade (T2T) segment in compulsory demat form for all investors
- Trading members must inform clients that purchase of REs confers only the right to participate in the rights issue or renounce the REs — not ownership of ordinary shares
- Contract notes/bills must carry a prominent disclaimer explaining the nature of REs and the risk of lapse
Regulatory Changes
No new regulatory changes introduced. The circular is issued in pursuance of:
- Regulation 3.1.1 of NSE (Capital Market) Trading Regulations Part A — admission of securities to dealings
- Regulation 2.5.5 of NSE (Capital Market) Trading Regulations Part A — specification of lot sizes
Compliance Requirements
- Trading Members must notify all clients about the commencement of trading in REs, including the ISIN (INE0PLZ20012), and clarify that REs are distinct from ordinary shares of Sunrest Lifescience Limited.
- Trading Members must include a prominent disclaimer in contract notes/bills for RE purchases stating that: (a) purchase of REs only gives the right to participate in the rights issue by submitting application money, or to renounce the REs before issue close; (b) REs neither subscribed nor renounced by the Issue Closing Date will lapse and be extinguished.
- All trading in SUNREST-RE must occur in compulsory demat mode.
Important Dates
| Event | Date |
|---|---|
| Circular effective date / Trading commencement | April 02, 2026 |
| Last day for renunciation of REs | April 27, 2026 |
| Date of suspension of RE trading | April 28, 2026 |
Impact Assessment
This circular has limited market-wide impact and is relevant only to existing shareholders of Sunrest Lifescience Limited who have been allotted Rights Entitlements. The Trade to Trade segment designation means each trade results in mandatory delivery, preventing intraday speculation. The compulsory demat requirement ensures settlement integrity. Shareholders who do not subscribe to the rights issue or renounce their REs by April 27, 2026 will lose their entitlements without compensation. Trading members carrying SME EMERGE clients should ensure timely client communication and compliant contract note disclosures.
Impact Justification
Routine SME EMERGE listing of Rights Entitlements for a small-cap company; limited market-wide impact, relevant only to existing shareholders of Sunrest Lifescience Limited participating in the rights issue.